Literature DB >> 21087446

Increased numbers of immature plasma cells in peripheral blood specifically overexpress chemokine receptor CXCR3 and CXCR4 in patients with ulcerative colitis.

S Hosomi1, N Oshitani, N Kamata, M Sogawa, H Okazaki, T Tanigawa, H Yamagami, K Watanabe, K Tominaga, T Watanabe, Y Fujiwara, K Maeda, K Hirakawa, T Arakawa.   

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease featuring infiltration by plasma cells producing immunoglobulins. We have reported previously the specific and significant proliferation of immature plasma cells in the inflamed colonic and pouch mucosa of UC patients. The aim of this study was to characterize peripheral blood immature plasma cells and the migration mechanisms of such immature plasma cells to inflamed sites in UC. The characteristics of peripheral blood immature plasma cells and chemokine receptor expression were examined by flow cytometry. Expression of mucosal chemokine was quantified using real-time reverse transcription-polymerase chain reaction and immunohistochemistry. The number of peripheral blood immature plasma cells was significantly higher in patients with active UC and active Crohn's disease (CD) than in healthy controls. The proportion of immature plasma cells was correlated positively with clinical activities of UC and CD. Many peripheral blood immature plasma cells were positive for CXCR3, CXCR4, CCR9 and CCR10. Expression of CXCR3 and CXCR4 in UC patients was significantly higher than in controls. CXCL9, CXCL10 and CXCL11 mRNA levels in colonic mucosa of inflamed IBD were higher than in controls. Immunofluorescence study also showed abundant CXCR3-positive immature plasma cells in the inflamed colonic mucosa of UC. Increased numbers of immature plasma cells may migrate towards inflammatory sites of UC via the CXCR3 axis, and may participate in UC pathogenesis.
© 2010 The Authors. Clinical and Experimental Immunology © 2010 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087446      PMCID: PMC3043312          DOI: 10.1111/j.1365-2249.2010.04290.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses.

Authors:  R H Duerr; S R Targan; C J Landers; L R Sutherland; F Shanahan
Journal:  Gastroenterology       Date:  1991-06       Impact factor: 22.682

Review 2.  Inflammatory bowel disease: etiology and pathogenesis.

Authors:  C Fiocchi
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

3.  In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis.

Authors:  T Hibi; M Ohara; K Toda; A Hara; H Ogata; Y Iwao; N Watanabe; M Watanabe; Y Hamada; K Kobayashi
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

4.  Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells.

Authors:  G Jego; N Robillard; D Puthier; M Amiot; F Accard; D Pineau; J L Harousseau; R Bataille; C Pellat-Deceunynck
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

5.  Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis.

Authors:  M Uguccioni; P Gionchetti; D F Robbiani; F Rizzello; S Peruzzo; M Campieri; M Baggiolini
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

6.  Significance of increased proliferation of immature plasma cells in the appendix of patients with ulcerative colitis.

Authors:  Tomohiro Kawachiya; Nobuhide Oshitani; Yoshio Jinno; Kenji Watanabe; Shiro Nakamura; Yasuhiro Fujiwara; Kazuhide Higuchi; Kiyoshi Maeda; Yukio Nishiguchi; Kosei Hirakawa; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Int J Mol Med       Date:  2005-03       Impact factor: 4.101

7.  Activated CD19+ B cell lamina propria lymphocytes in ulcerative colitis.

Authors:  B R Yacyshyn
Journal:  Immunol Cell Biol       Date:  1993-08       Impact factor: 5.126

8.  Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.

Authors:  S Gasperini; M Marchi; F Calzetti; C Laudanna; L Vicentini; H Olsen; M Murphy; F Liao; J Farber; M A Cassatella
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

9.  Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis.

Authors:  M M Kawano; K Mihara; N Huang; T Tsujimoto; A Kuramoto
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

10.  Identification of early plasma cells in peripheral blood and their clinical significance.

Authors:  Y Harada; M M Kawano; N Huang; M S Mahmoud; I A Lisukov; K Mihara; T Tsujimoto; A Kuramoto
Journal:  Br J Haematol       Date:  1996-01       Impact factor: 6.998

View more
  23 in total

1.  Over-expression of CXCR4 on mesenchymal stem cells protect against experimental colitis via immunomodulatory functions in impaired tissue.

Authors:  Xingxing Liu; Dongmei Zuo; Heng Fan; Qing Tang; Zhexing Shou; Dan Cao; Zhou Zou
Journal:  J Mol Histol       Date:  2013-10-12       Impact factor: 2.611

2.  'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared.

Authors:  Michaela D Filiou; Ahmed Shamsul Arefin; Pablo Moscato; Manuel B Graeber
Journal:  Neurogenetics       Date:  2014-06-15       Impact factor: 2.660

3.  Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.

Authors:  Vanessa Mitsialis; Sarah Wall; Peng Liu; Jose Ordovas-Montanes; Tamar Parmet; Marko Vukovic; Dennis Spencer; Michael Field; Collin McCourt; Jessica Toothaker; Athos Bousvaros; Alex K Shalek; Leslie Kean; Bruce Horwitz; Jeffrey Goldsmith; George Tseng; Scott B Snapper; Liza Konnikova
Journal:  Gastroenterology       Date:  2020-05-16       Impact factor: 22.682

4.  Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression.

Authors:  Jerod A Skyberg; Amy Robison; Sarah Golden; Maryclare F Rollins; Gayle Callis; Eduardo Huarte; Irina Kochetkova; Mark A Jutila; David W Pascual
Journal:  J Leukoc Biol       Date:  2011-06-21       Impact factor: 4.962

5.  Plasmablast frequency and trafficking receptor expression are altered in pediatric ulcerative colitis.

Authors:  Nicole J Tarlton; Caroline M Green; Nicole H Lazarus; Lusijah Rott; Anthony P Wong; Oren N Abramson; Martina Bremer; Eugene C Butcher; Tzvia Abramson
Journal:  Inflamm Bowel Dis       Date:  2012-04-05       Impact factor: 5.325

6.  Functional characterization of CXCR4 in mediating the expression of protein C system in experimental ulcerative colitis.

Authors:  Xuhong Lin; Huichao Wang; Yuxia Li; Jingnan Yang; Ruilin Yang; Dandan Wei; Junjie Zhang; Desheng Yang; Bin Wang; Xuequn Ren; Guanchang Cheng
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.

Authors:  Zachary S Wallace; Hamid Mattoo; Mollie Carruthers; Vinay S Mahajan; Emanuel Della Torre; Hang Lee; Maria Kulikova; Vikram Deshpande; Shiv Pillai; John H Stone
Journal:  Ann Rheum Dis       Date:  2014-05-09       Impact factor: 19.103

Review 8.  Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.

Authors:  Dylan K McDaniel; Kristin Eden; Veronica M Ringel; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

9.  CXCR4/IgG-expressing plasma cells are associated with human gastrointestinal tissue inflammation.

Authors:  Clarisa M Buckner; Susan Moir; Lela Kardava; Jason Ho; Brian H Santich; Leo Jin Young Kim; Emily K Funk; Amy K Nelson; Britanny Winckler; Cheryl L Chairez; Narda L Theobald-Whiting; Sandra Anaya-O'Brien; Meghna Alimchandani; Martha M Quezado; Michael D Yao; Joseph A Kovacs; Tae-Wook Chun; Anthony S Fauci; Harry L Malech; Suk See De Ravin
Journal:  J Allergy Clin Immunol       Date:  2013-12-25       Impact factor: 10.793

10.  Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design.

Authors:  Christopher J Tyler; Mauricio Guzman; Luke R Lundborg; Shaila Yeasmin; Tamara Perez-Jeldres; Andres Yarur; Brian Behm; Parambir S Dulai; Derek Patel; Giorgos Bamias; Jesús Rivera-Nieves
Journal:  J Crohns Colitis       Date:  2020-10-05       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.